Tomer Kariv

Tomer Kariv has an estimated net worth of $61.2 Million. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., VBI Vaccines Inc/BC, LogicBio Therapeutics, Inc., 89bio, Inc., Eloxx Pharmaceuticals, Inc., and Arno Therapeutics, Inc.

2013 was Tomer Kariv's most active year for acquiring shares with 28 total transactions. Tomer Kariv's most active month to acquire stocks was the month of September. 2020 was Tomer Kariv's most active year for disposing of shares, totalling 11 transactions. Tomer Kariv's most active month to dispose stocks was the month of September. 2019 saw Tomer Kariv paying a total of $5,800,000.00 for 1,565,540 shares, this is the most they've acquired in one year. In 2025 Tomer Kariv cashed out on 4,787,331 shares for a total of $84,975,125.25, their largest year based on trade value.